Vitamin K2 for chronic kidney disease with high urine protein
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial studies whether vitamin K2 can help people with chronic kidney disease (kidney damage that lasts months or longer), especially those with higher protein levels in the urine. It compares vitamin K2 use in a specific group and watches kidney-related health outcomes and safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older, and able to take part for the study period
- Have chronic kidney disease that is not on dialysis, with kidney filtration (eGFR) between 30 and 89
- Have a urine protein test (albumin-to-creatinine ratio) of 30 mg/g or higher
- Have a potassium blood test below 5 mEq/L
- Have been newly diagnosed with high blood pressure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking coenzyme Q10 can improve chronic kidney disease in adults with moderate kidney function and higher urine protein. It also looks at safety, especially for blood pressure and potassium levels.
This study tests if careful potassium management can help people with chronic kidney disease (CKD) safely take higher doses of blood pressure medicines called ACE inhibitors or ARBs, which are known to protect the kidneys. You may be eligible if you have moderate to advanced CKD and are already on a moderate dose of one of these medications.
This study tests whether vitamin K2 can help prevent bone loss caused by steroid treatment in children with nephrotic syndrome. If your child meets the requirements, taking vitamin K2 may protect their bones while they receive steroids.
This study tests whether taking vitamin K2 can help people with low bone density (osteopenia or osteoporosis) who have a specific change in the VDR gene. If you have this gene change, vitamin K2 may work better for you than standard supplements.
This trial tests whether a special diet supplement (Ketoanalogue) can help protect your muscles while you follow a moderate protein diet. It is for people with chronic kidney disease stage 4 or 5 who are not on dialysis or have not had a kidney transplant.
This trial tests whether taking vitamin K2 can reduce the number of migraine days per month. It may help people who have had episodic migraines for at least a year and meet specific migraine frequency and medication requirements.
Hear when a new Chronic Kidney Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.